A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABT-493/ABT-530 IN COMBINATION WITH SOFOSBUVIR AND RIBAVIRIN IN PARTICIPANTS WITH HEPATITIS C VIRUS WHO DID NOT RESPOND TO TREATMENT IN A PREVIOUS ABBVIE CLINICAL STUDY: